Financial insights of RFL-WT

MyFinsight

For the year ending 2025-07-31, RFL-WT made $1,642K in revenue. -$30,520K in net income. Net profit margin of -1858.71%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-07-31
Benefit from income taxes	-2,553
Total revenue-Infusion Technology	93
Total revenue	917
Loss on impairment of goodwill	3,100
Total revenue-Rental Third Party	197
Total revenue-Rental Related Party	112
Total revenue-Product Revenue	515
Cost of product revenue-Infusion Technology Revenue	106
Cost of product revenue-Product Revenue	28
General and administrative	13,781
Research and development	12,823
Depreciation and amortization	288
In-process research and development expense	0
Loss from operations	-29,159
Interest income	1,996
Realized gain on available-for-sale securities	178
Unrealized (loss) gain on investment - cyclo	-5,144
Unrealized (loss) gain on convertible notes receivable, due from cyclo	-719
Interest expense	658
Other income, net	310
Loss on initial investment in day three upon acquisition	0
Realized loss on investment in equity securities	0
Realized gain on investment - cyclo	0
Unrealized gain on investment - hedge funds	0
Recovery of receivables from cornerstone	0
Loss before income taxes	-33,196
Equity in loss of day three	0
Consolidated net loss	-30,643
Net loss attributable to noncontrolling interests	-123
Net loss attributable to rafael holdings, inc	-30,520

Basic (in dollars per share)	-1.04
Basic (in shares)	29,422,221
Diluted (in dollars per share)	-1.04
Diluted (in shares)	29,422,221